NovaBay Pharmaceuticals, Inc. - Common Stock, $0.01 par value (NBY)

Historical Holders from Q2 2024 to Q3 2025

Symbol
NBY on NYSE
CUSIP
66987P409
Type / Class
Equity / Common Stock, $0.01 par value
Shares outstanding
126M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
227K
Holdings value
$290K
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
13
Number of buys
7
Number of sells
-7
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of NovaBay Pharmaceuticals, Inc. - Common Stock, $0.01 par value (NBY)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
R01 Fund LP 45.1% +181% $74.2M $72.7M 56.8M +4780% R01 Fund LP Oct 16, 2025
Framework Ventures IV L.P. 45.1% +181% $74.2M $72.7M 56.8M +4780% Framework Ventures IV L.P. Oct 16, 2025
Lazar David E. 19.99% 0% $2M $403K 1.5M +25.2% David E. Lazar Oct 16, 2025
POPLAR POINT CAPITAL MANAGEMENT LLC 17.52% 0% $1.36M 1.02M 0% Poplar Point Capital Management LLC Oct 15, 2025

Institutional Holders of NovaBay Pharmaceuticals, Inc. - Common Stock, $0.01 par value (NBY)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 227K $290K +$136K $1.28 13
2025 Q2 219K $127K -$84.5K $0.58 12
2025 Q1 362K $212K +$113K $0.59 15
2024 Q4 167K $101K +$22K $0.60 14
2024 Q3 126K $87.5K +$79.5K $0.69 12
2024 Q2 11.5K $25.4K +$25.4K $2.24 7